|
Sanofi to acquire Ablynx for €3.9 Billion
|
29 January 2018 |
|
Sanofi and Regeneron to accelerate and expand investment for cemiplimab and dupilumab development programs
|
10 January 2018 |
|
Sanofi explores combination treatments for multiple myeloma in new late-stage trials
|
07 December 2017 |
|
Sanofi, Principia agree to develop multiple sclerosis drug candidate
|
09 November 2017 |
|
Sanofi and Regeneron announce that cemiplimab (REGN2810) has received FDA Breakthrough Therapy designation for advanced cutaneous squamous cell carcinoma
|
08 September 2017 |
|
Sanofi and Regeneron announce FDA Approval of Kevzara® (sarilumab) for the treatment of moderately to severely active rheumatoid arthritis in adult patients
|
23 May 2017 |
|
Sanofi Pasteur and MSD end joint vaccines business in Europe
|
16 January 2017 |
|
Sanofi and Verily Life Sciences announce launch of Onduo, a joint venture to develop comprehensive diabetes management platform
|
12 September 2016 |
|
Sanofi Pasteur signs research agreement for Zika vaccine
|
06 July 2016 |
|
Sanofi announces expiration of Hart-Scott-Rodino waiting period regarding proposed acquisition of Medivation
|
16 June 2016 |